Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
British Journal of Cancer|January 26, 2000
CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitroG Molema, J W Tervaert, B J Kroesen, et al.The Journal of Biological Chemistry|March 30, 2001
Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondriaB J Kroesen, B Pettus, C Luberto, et al.International Journal of Cancer|April 16, 1998
Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomasW Helfrich, B J Kroesen, R C Roovers, et al.Journal of Hematotherapy|October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspectsB J Kroesen, R A Janssen, J Buter, et al.British Journal of Cancer|April 20, 2001
Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cellsS Withoff, M N Bijman, A J Stel, et al.International Journal of Cancer|June 9, 1995
Reduction of EGP-2-positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat modelB J Kroesen, W Helfrich, A Bakker, et al.Oncogene|December 19, 2006
Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphomaJ Kluiver, A van den Berg, D de Jong, et al.British Journal of Cancer|September 1, 1995
Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patientsR A Janssen, B J Kroesen, J Buter, et al.British Journal of Cancer|October 1, 1994
Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2B J Kroesen, J Buter, D T Sleijfer, et al.Journal of Immunological Methods|March 22, 2000
A rapid and versatile method for harnessing scFv antibody fragments with various biological effector functionsW Helfrich, H J Haisma, V Magdolen, et al.Pageof 3